Verrica Pharma Announces Board & Executive Changes
Ticker: VRCA · Form: 8-K · Filed: Apr 25, 2025 · CIK: 1660334
| Field | Detail |
|---|---|
| Company | Verrica Pharmaceuticals Inc. (VRCA) |
| Form Type | 8-K |
| Filed Date | Apr 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, executive-compensation
TL;DR
Verrica Pharma shakes up board and exec pay on April 22nd.
AI Summary
Verrica Pharmaceuticals Inc. announced on April 22, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory plans.
Why It Matters
Changes in leadership and executive compensation can signal shifts in company strategy or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal restructuring or strategic shifts that may carry inherent risks.
Key Players & Entities
- Verrica Pharmaceuticals Inc. (company) — Registrant
- April 22, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 484-453-3300 (phone_number) — Registrant's telephone number
FAQ
What specific items are being reported under the 8-K filing?
The filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is the date of the earliest event reported in this 8-K?
The date of the earliest event reported is April 22, 2025.
In which state was Verrica Pharmaceuticals Inc. incorporated?
Verrica Pharmaceuticals Inc. was incorporated in Delaware.
What is the principal executive office address for Verrica Pharmaceuticals Inc.?
The principal executive offices are located at 44 W. Gay St., Suite 400, West Chester, PA 19380.
What is the IRS Employer Identification Number (EIN) for Verrica Pharmaceuticals Inc.?
The IRS Employer Identification Number is 46-3137900.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding Verrica Pharmaceuticals Inc. (VRCA).